Saudi Arabia Digital Diabetes Management Market ( 2026 - 2033)

Saudi Arabia Digital Diabetes Management Market Summary

The Saudi Arabia digital diabetes management market size was valued at USD 136.7 million in 2025 and is projected to grow from USD 148.9 million in 2026 to USD 282.8 million by 2033, at a CAGR of 9.6% from 2026 to 2033. The rising prevalence of diabetes in the region is a crucial driver, necessitating the adoption of advanced digital solutions for effective management. For instance, according to the International Diabetes Federation (IDF), over 10% of the population in Saudi Arabia currently has diabetes, and this prevalence is projected to nearly double by the year 2045.

The IDF report states that 4,274.1 thousand individuals in Saudi Arabia are diagnosed with diabetes, along with an additional 1,863.5 thousand cases that are undiagnosed. By 2030, the number of diabetes cases is expected to reach 5,631.0 thousand, and by 2045, it is forecasted to increase to 7,537.3 thousand. Growing awareness of diabetes and the importance of regular monitoring and management among the population is driving the demand for digital diabetes management solutions.

In addition, the increasing adoption of smartphones and other digital devices in Saudi Arabia supports the use of digital diabetes management platforms, as these devices provide convenient access to health information and monitoring tools. The government's initiatives to promote digital healthcare solutions and improve access to healthcare services are also contributing to market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

According to the International Trade Administration, the healthcare industry remains a top priority for the Saudi Arabian government, which accounts for 60% of the total healthcare expenditures in the Gulf Cooperation Council (GCC) as of January 2024. With a budget of USD 1.5 million, the government is investing in healthcare IT and digital transformation initiatives. As part of Vision 2030, the country prioritizes local manufacturing and technology transfer, conducts clinical trials domestically, and enhances the training of the Saudi workforce.

Technological advancements, such as wearable devices and mobile applications for diabetes management, are improving the effectiveness and convenience of these digital solutions. Furthermore, integrating artificial intelligence and machine learning algorithms into these platforms enables personalized and proactive diabetes management, thereby driving further market growth.

The Ministry of Health (MoH) oversees all healthcare-related operations and services in the nation. The Health Holding Company is set to take over the daily management of healthcare services from the MoH and deliver services to beneficiaries through primary healthcare enhancement initiatives, which encompass advanced digital health solutions and remote medical care.

Analyst Perspective

The digital diabetes management market in Saudi Arabia is expanding as healthcare providers increasingly integrate connected technologies into chronic disease care. The growing adoption of continuous glucose monitoring systems, mobile health applications, cloud-based data platforms, and remote patient monitoring is improving how diabetes is tracked and managed. This digital shift is supported by Vision 2030 initiatives aimed at strengthening healthcare infrastructure and accelerating digital health adoption. Companies that can deliver interoperable platforms, secure data management, and user-friendly patient experiences are well-positioned to capture future growth. As demand shifts from standalone devices to connected care ecosystems, collaboration among device manufacturers, software providers, and healthcare institutions will become increasingly important.

Product Insights

The continuous glucose monitoring systems segment captured the largest market share, over 35.0%, in 2025. Continuous glucose monitoring systems (CGMS) are devices that offer real-time insights into glucose levels and enhance diabetes management. These systems consist of wearable sensors that continuously monitor glucose levels in interstitial fluid, providing users with valuable data to make informed decisions about their diabetes management.

In Saudi Arabia, the prevalence of diabetes is high, making CGMS an essential tool for individuals with diabetes to monitor their glucose levels effectively. Nemaura Medical specializes in developing daily, disposable, non-invasive wearable glucose sensors. In addition, it provides digital tools for managing diabetes and recently introduced CGM-guided insulin dose adjustment. For instance, in February 2025, Insulet Corporation launched the Omnipod 5 Automated Insulin Delivery System in Saudi Arabia as part of its expansion in the Middle East. The system integrates with continuous glucose monitoring (CGM) technology to automatically adjust insulin delivery, enhancing digital diabetes management and expanding access to advanced connected diabetes care across the Kingdom. Several factors, including increasing awareness about diabetes management, advancements in sensor technology, and the rising demand for personalized healthcare solutions, drive the adoption of CGMS in the country.

Smart Insulin Pens and Smart Glucose Meters are anticipated to grow significantly during the forecast period. These innovative devices integrate digital technology to provide real-time monitoring of blood glucose levels and insulin dosing, enhancing precision and convenience for patients. With the rising prevalence of diabetes in Saudi Arabia, the demand for these smart devices is increasing rapidly. They offer personalized insights, seamless data sharing with healthcare providers, and improved treatment.

Type Insights

The wearable devices segment captured the largest market share, at around 55.0% in 2025, and is expected to grow at the fastest CAGR over the forecast period. These devices encompass a range of technologies, including continuous glucose monitoring (CGM) systems, smart insulin pumps, and fitness trackers with integrated glucose monitoring and physical activity tracking capabilities.

They enable users to make informed decisions about their health, leading to enhanced adherence to treatment regimens and improved outcomes. In general, wearable devices are crucial for enhancing diabetes management in Saudi Arabia. They encourage continuous monitoring, improve treatment adherence, and empower patients to embrace healthier lifestyles. With the integration of advanced technologies and the growing acceptance of wearable devices, the market is experiencing rapid expansion, promising a future in which managing diabetes is more convenient and effective.

The hand-held devices segment is expected to experience the fastest CAGR during the forecast period, driven by rising demand for portable, user-friendly diabetes-monitoring solutions. In addition, rising adoption of self-monitoring practices, improved connectivity with digital health platforms, and growing awareness of diabetes management are supporting segment growth. Furthermore, ongoing technological advancements and expanding access to smart healthcare devices are expected to accelerate the adoption of handheld diabetes management devices.

End Use Insights

The home setting segment has captured the largest market share, at around 65.0%, in 2025. The home setting segment encompasses a wide range of products and services designed to facilitate diabetes management within the comfort of patients' homes. This segment includes digital health tools such as glucometers, continuous glucose monitoring (CGM) systems, intelligent insulin pens, and mobile applications tailored for diabetes management.

Patients in Saudi Arabia are increasingly adopting digital solutions to monitor their blood glucose levels, track insulin dosages, and manage their diet and exercise routines from the convenience of their homes. These digital tools empower patients to take charge of their health and make informed decisions about their diabetes care.

Healthcare providers are increasingly using telemedicine and remote monitoring technologies to offer virtual consultations and support for patients at home. This approach enables regular monitoring of patients' health and allows for timely interventions when necessary, ultimately improving outcomes in diabetes management. For instance, in May 2024, Bayer and Huma expanded their digital health collaboration to Saudi Arabia by launching the Bayer Aspirin Heart Health Risk Assessment. Huma also introduced a digital diabetes care pathway within the Seha Virtual Hospital. This initiative utilizes AI-powered remote patient monitoring and digital care technologies to enhance chronic disease management, including diabetes, in alignment with Saudi Vision 2030. Initially, the program will focus on supporting patients with diabetes and cardiovascular conditions.

The hospitals segment is expected to register the fastest CAGR during the forecast period, driven by increasing adoption of connected diabetes management solutions and integrated digital healthcare systems. In addition, rising diabetes-related hospital admissions and growing investments in smart healthcare infrastructure are supporting segment growth. Furthermore, expanding use of remote patient monitoring and electronic health records is expected to accelerate the adoption of digital diabetes management solutions in hospitals.

Key Saudi Arabia Digital Diabetes Management Company Insights

The Saudi Arabia digital diabetes management industry features a range of global, regional, and local players, making it a competitive market. The world’s leading companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share. Saudi Arabia's digital diabetes management product manufacturers are investing heavily in product enhancements and new product development.

Key Saudi Arabia Digital Diabetes Management Companies

• Salehiya Medical Company

• Al Jeel Medical

• Al-Hammad Medical Services Co. Ltd.

• Johnson & Johnson

• Medtronic plc

• Philips

• DexCom, Inc.

• Ascensia Diabetes Care Holdings AG

• Roche Diabetes Care

• Tandem Diabetes Care, Inc.

Recent Developments

• In October 2025, Salehiya Medical highlighted Saudi Arabia's launch of the world's first Digital Diabetes Command Center, enabling real-time monitoring of diabetes patients through connected digital health technologies and AI-driven clinical decision support, reinforcing the Kingdom's digital healthcare transformation.

• In February 2025, Medtronic collaborated with leading diabetes specialists in Saudi Arabia to expand the adoption of the MiniMed 780G automated insulin delivery system, supported by local clinical evidence demonstrating improved glycemic control among Saudi patients during Ramadan.

Saudi Arabia Digital Diabetes Management Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Saudi Arabia digital diabetes management market report based on product, type, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Smart Glucose Meters

  • Continuous Glucose Monitoring Systems

  • Smart Insulin Pens

  • Smart Insulin Pumps/Closed Loop Systems

  • Apps

    • Digital Diabetes Management Apps 

    • Weight & Diet Management Apps

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Wearable Devices

  • Hand-held Devices

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Home Settings

  • Others